Latest news
Loading news…
Epixis
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Paris, Ile-de-France, France Founded 2003 1-10 employees For Profit
Epixis SA, a biotechnology company, engages in the development of advanced immuno-therapies based on recombinant virus-like particles
Epixis was acquired by VBI Vaccines in 2011.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Active products
- 2
- Patents granted
- 1
- Trademarks
- 0
- Top patent class
- c12
- IT spend
- $9M
Company Info
- Founded
- 2003
- Employees
- 1-10
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- HQ
- Paris, Ile-de-France, France
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Sep 15, 2011
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -0.2
- Trend (90d)
- -0.6
Key People at Epixis
CEO
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Epixis
Loading news…
FAQs about Epixis
People who checked this page also checked these
Browse the full Acquirezy directory.